Fate Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Fate Therapeutics Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Fate Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Fate Therapeutics Inc.

Back to companies

Fate Therapeutics Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Fate Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230390337A1 Application Engineered ipsc and persistent immune effector cells A61K35/17; A61P35/00; C07K14/52; C07K14/7155; A61K39/4631; A61K2239/24 December 07, 2023
US20230381235A1 Application Multiplexed engineered ipscs and immune effector cells targeting solid tumors C12N5/0636; C12N5/0646; A61K35/17; A61P35/00; C07K14/7051; C07K14/70521; C07K14/70539; A61K39/4631 November 30, 2023
CN108291237B Grant 用于诱导和维护基态多能性的平台 C12N15/113; C12N15/85; C12N15/86; C12N2015/8518; C12N2015/8536; C12N2501/602; C12N2501/603; C12N2501/605; C12N2501/606; C12N2740/16043; C12N2760/18641; C12N2760/18843; C12N2800/108; C12N2840/002; C12N2840/007; C12N5/0696 November 21, 2023
ES2953925T3 Grant Ingeniería genómica de células pluripotentes C12N2501/15; C12N2506/11; C12N15/85; C12N2800/80; C12N5/0634; C12N15/1138; C12N15/90; C12N2501/515; C12N2506/03; C12N5/0636; C12N2501/51; C12N2501/25; A61K2039/5158; A61K2039/5156; C12N2501/505; C12N2501/727; C12N2510/00; C12N15/907; C12N15/11; C07K16/2803; A61P35/00; C12N2800/107; C12N2310/20; C12N2501/599; C12N2830/00; C12N2840/203; C07K14/7051; Y02A50/30; C07K2319/03; A61K2035/124; A61K35/17; C12N2501/998; C12N5/0696; C07K14/70503; C07K2319/33; A61P35/02; A61K39/0011; C12N9/22 November 17, 2023
US20230357716A1 Application Cells having solid tumor targeting backbone and use thereof C12N5/0634; A61P35/00; C07K14/7051; C07K16/3015; C07K2317/565; C07K2317/622; C07K2319/02; C07K2319/03 November 09, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer